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Available online 30 October 2010Abstract Embryonic stem cell (ESC) derivatives offer promise for generating clinically useful tissues for transplantation,
yet the specter of producing tumors in patients remains a significant concern. We have developed a simple method that
eliminates the tumorigenic potential from differentiated ESC cultures of murine and human origin while purifying
lineage-restricted, definitive endoderm-committed cells. A three-stage scheme utilizing magnetic bead sorting and specific
antibodies to remove undifferentiated ESCs and extraembryonic endoderm cells, followed by positive selection of definitive
endoderm cells on the basis of epithelial cell adhesion molecule (EpCAM) expression, was used to isolate a population of
EpCAM+SSEA1–SSEA3– cells. Sorted cells do not form teratomas after transplantation into immunodeficient mice, but display
gene and protein expression profiles indicative of definitive endoderm cells. Sorted cells could be subsequently expanded
in vitro and further differentiated to express key pancreas specification proteins. In vivo transplantation of sorted cells resulted
in small, benign tissues that uniformly express PDX1. These studies describe a straightforward method without genetic
manipulation that eliminates the risk of teratoma formation from ESC differentiated derivatives. Significantly, enriched
populations isolated by this method appear to be lineage-restricted definitive endoderm cells with limited proliferation
capacity.
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Optimistic views of regenerative medicine have envisioned
the use of stem cells as eventually curative for many types of
human disorders, including ischemic heart disease, Parkin-
sonism, diabetes, and many other degenerative or geneti-
cally deficient disease conditions. The initiation of the first
FDA-approved clinical trial using human ESC-derived cells
(Alper, 2009) has raised the anxiety of many scientists who
fear that should this trial fail, it could endanger public
acceptance and respectability of the entire field of
embryonic stem cell research. Potential tumorigenicity of
donor cells is a major concern. Adding to this unease is the
recent report that a child with ataxia telangiectasia
developed multifocal tumors of the brain and spinal cord
4 years after treatment with human neural stem cells
(Amariglio et al., 2009) originating from at least two donors,
even though the cells were relatively freshly derived from
chromosomally normal fetuses.
Numerous published reports have examined the potential
of differentiated cell types derived from mouse and human
ESCs to repair nonhuman target organs in intact animals.
Recent studies, however, have yielded both encouragement
and caution, with restoration of function evident to some
degree in many cases, but coexisting in others with the
troubling finding that the grafts contained evidence of
cancerous growth (Fujikawa et al., 2005; Ishii et al., 2007;
Kroon et al., 2008; Leor et al., 2007; Li et al., 2009; Roy et
al., 2006; Hentze et al., 2009).
Although ESCs offer great promise in regenerative
medicine in terms of both the variety of tissues obtainable
and the expansion potential of precursors, their slowly
emergent clinical status reflects, in part, an inherent risk
that arises due to the lack of understanding of the hazard of
formation of teratomas arising from differentiated ESC-
derivative populations. In view of the magnitude of this risk,
selection schemes have been devised using genetically
modified cell lines to either remove undifferentiated ES
cells or purify ESC-derived populations that have been
directed into specific lineages (Ishii et al., 2007; Kattman
et al., 2006; Huber et al., 2007; Anderson et al., 2007;
Fukuda et al., 2006; Soria et al., 2000; Saldeen et al., 2006).
However, few, if any, of these experiments have exhaus-
tively tested such cell populations for their tumor potential
in vivo. In addition, despite genetic selection, the resulting
populations still contained some undifferentiated ESCs (Ying
et al., 2003) or produced obvious tumor growths in animal
transplant tests (Ishii et al., 2007; Li et al., 2009; Chung et
al., 2006). An explanation for these observations may lie in
the less than ideal stringency of a single selection step.
We desired to address the concern of residual tumorige-
nicity in one instance of high priority in the field of
regenerative medicine: the derivation of differentiated
pancreatic β cells from ESCs. Aiming to achieve efficient
elimination of tumorigenicity of heterogeneous differentiat-
ed ESC-derived populations, we devised a three-step
selective process that appears to completely remove all
tumorigenic cells from concurrently enriched definitive
endoderm cells, which include pancreatic precursors and
progeny, while simultaneously eliminating another trouble-
some contamination: extraembryonic visceral endoderm(VYS). Commonly generated during typical ESC differentia-
tion cultures during which postgastrulation germ layer
derivatives are formed, VYS has overlapping genetic expres-
sion profiles with definitive endoderm including, for exam-
ple, alpha fetoprotein, Foxa2, Sox17, Hnf4α, and Hnf1β
(Sherwood et al., 2007; Dufort et al., 1998), that can
confound careful gene expression analyses and potentially
lead to erroneous conclusions.
Effective methods for enriching definitive endoderm-
committed cells would be of great value and have been
pursued. To this end, several studies have taken advantage
of the possible differential expression of CXCR4 in definitive
versus visceral endoderm, and studied sorted CXCR4+ cells
(D'Amour et al., 2005; Gouon-Evans et al., 2006; Yasunaga et
al., 2005). However, CXCR4 may not be an ideal marker to
use for definitive endoderm enrichment for the following
reasons. First, some studies have shown that CXCR4 is also
highly expressed in visceral endoderm (Sherwood et al.,
2007), and in many neuronal and mesodermal cells at early
stages (McGrath et al., 1999). CXCR4 is expressed in many
nonendodermal cell populations including neural, vascular,
cardiac and skeletal muscle satellite cells, and lymphopoie-
tic, myelopoietic, and hematopoietic stem cells (reviewed in
(Miller et al., 2008)). Furthermore, CXCR4 expression
appears to be downregulated in definitive endoderm after
e8.5 of mouse embryonic development (McGrath et al.,
1999), thereby potentially allowing some highly desired
endodermal cell types in ESC-derived cultures to escape
selection. Lastly, selective techniques would ideally be able
to simultaneously remove all residual cell populations that
could give rise to teratomas; however, as CXCR4 is also
expressed in undifferentiated ESCs (our unpublished obser-
vations and (Baharvand et al., 2006)) this is not likely to be
the case in CXCR4+ selected cell populations.
We have based our selection scheme on classic markers
that have been extensively characterized and found to be
exclusively expressed on only certain cell types in the mouse
embryo. The stage-specific embryonic antigens (SSEA), first
described in 1978 by Solter and Knowles, are well-known
highly specific markers (SSEA1 and SSEA3) for undifferenti-
ated mouse ESCs (Solter and Knowles, 1978) or VYS
endoderm cells (Fox et al., 1984), respectively. In addition,
the cell surface marker epithelial cell adhesion molecule
(EpCAM) has been recently described as exclusively
expressed on definitive endoderm cells after e9.5 (Sherwood
et al., 2007), is known to be expressed in fetal pancreas
(Cirulli et al., 1995), and has a role in the morphological
development of the pancreas (Cirulli et al., 1998). Prior to
e9.5, EpCAM is also expressed on inner cell mass (ICM) and
VYS cells as well as ESCs, which are derived from ICM cells.
We therefore reasoned that if we initially removed ESCs and
VYS cells present in ESC-differentiated cultures by sequen-
tial negative selection steps, using magnetic activated cell
sorting (MACS) employing anti-SSEA1 and anti-SSEA3 anti-
bodies, we could then positively select from the remaining
SSEA1–/SSEA3– population only those cells expressing
EpCAM, which should represent highly purified definitive
endoderm cells. In this paper, we present the results of a
unique three-stage selection scheme to purify definitive
endoderm cells, the in vitro characterization of selected
cells, and results of in vivo growth demonstrating their
inability to form teratomas or tumor growths. In addition, we
145Non-tumorigenic endoderm stem cellspresent surprising results that suggest a novel way to further
differentiate and/or select from purified definitive endo-
derm cells only those precursor cells expressing PDX1, the
hallmark for posterior foregut/pancreatic-committed gut
endoderm.
Results and discussion
Rationale for MACS selection strategy of
differentiated ESC cultures
As definitive endoderm and pancreatic progenitors would be
useful starting materials for generating replacement thera-
pies for diabetes, we focused on isolating these cells from
differentiated ESC cultures. In previous experiments, we
determined that PDX1+ progenitor cells developed and
remained present over an extended period in ESC cultures,
thus facilitating their detection and removal from differen-
tiated populations (Kahan et al., 2003). We began by testing
antibody to EpCAM, restricted to definitive endoderm by E9
in the developing embryo, for its ability to include cells
expressing PDX1, the first diagnostic marker for regional
pancreatic specification. Virtually all PDX1+ cells in murine
EB7+21 cultures (7 days EB culture followed by 21 days
postplating) coexpressed EpCAM (Fig. 1a). Notably, even
small numbers of PDX1+ cells were typically surrounded by a
broader field of EpCAM+ cells (Fig. 1b). These results
suggested that sorting for EpCAM expression could isolate
definitive endoderm-committed cells that included PDX1+
foregut/pancreatic progenitors.
To determine the specificity of EpCAM staining in
differentiating ESC cultures, we further examined cells for
coexpression of EpCAM and markers of other nonendoderm
cell types. No cells costaining for EpCAM and cytokeratin 14
(CK14), a marker of ectodermally derived basal epidermal
cells prevalent in nonspecific differentiated ESC cultures,
were observed either in differentiating ESC cultures or in
cells of an established keratinocyte stem cell line (Fig. 1c).
Likewise, EpCAM was not coexpressed with mesoderm or
neuronal markers including vimentin, myosin, ß-tubulin, and
nestin (Figs. 1d–g), results that agree with those previously
obtained using quantitative RT-PCR (QPCR) to analyze
embryonic sites of EpCAM expression (Sherwood et al.,
2009). However, in accordance with other published reports
(Gonzalez et al., 2009; Anderson et al., 1999), we observed
abundant costaining for EpCAM and either SSEA-1 or SSEA-3/
4, which mark undifferentiated murine ESCs or VYS cells,
respectively, in differentiating mouse ESC cultures. For
example, in FACS analyses of early cultures at EB7+8 we found
that ~60% of EpCAM+ cells expressed SSEA1, and ~20–25% of
EpCAM+ cells coexpressed SSEA3. Thus, if cultures were
sorted for EpCAM alone, the majority of cells isolated at this
stage would represent undifferentiated, highly tumorigenic
ESCs or contaminating primitive endoderm VYS cells that
express many genes in common with definitive endoderm.
We therefore devised a multistep isolation strategy that
first involved removal of both SSEA1+ (undifferentiated ESC)
and SSEA3+ (VYS) cells, followed by positive selection for
EpCAM+ cells (Fig. 2a). This protocol has been repeated over
50 times; typically, about 10% of the starting material is
selected and viability of sorted cells is generally greater than90%. To ascertain whether MACS sorting enriches for EpCAM+
cells, we examined cells before and after MACS sorting by
flow cytometry. Whereas less than 50% of the presort
population at EB7+21 is EpCAM+ (which includes ESC and VYS
cells), virtually the entire population is EpCAM+ after sorting
(Fig. 2b). Oct4 expression, characteristic of undifferentiated
ESCs, appreciably diminishes during cell differentiation and
is further significantly reduced by sorting (Fig. 2c). Tran-
script levels of pluripotency markers Nanog and Sox2 were
also decreased after sorting at 3 weeks differentiation (20-
and 25-fold, respectively; data not shown). Antibody staining
revealed that there was very limited or no expression of
OCT4, Nanog, or SOX2 protein following sorting (Fig. S1). To
determine if the protocol successfully depleted VYS cells,
pre- and postsorted cells were stained for SSEA4, an
additional murine marker of this lineage. No SSEA4-stained
cells were observed in postsorted cells (Fig. 2d). Overall,
these results demonstrate that MACS sorting results in a
highly purified EpCAM+ population that is significantly
depleted of ES and VYS cells.Tumorigenicity of MACS sorted cells
To determine the teratoma-forming potential of sorted
EpCAM+ SSEA1– SSEA3– cells in vivo, we injected freshly
sorted cells into subcutaneous abdominal sites in NOD/SCID
mice (Fig. 3a). Undifferentiated ESCs, unsorted populations
of differentiated ESCs, and column-discard EpCAM– cell
populations were used as controls. As expected, large,
rapidly growing teratomas arose uniformly after injection of
undifferentiated ESCs or unsorted cells of the same
differentiation stage, and in a few cases from the EpCAM–
population as well, generally reaching N15 mm by 3–5 weeks
postinoculation. The percentage of inocula that resulted in
tumor growths exceeding 3 mm during 6 weeks following
injection of different populations is shown in Fig. 3b.
Strikingly, tumors never formed in animals following injec-
tion of freshly sorted EpCAM+ cells, even after up to 23 weeks
(Figs. 3b and c).
An ongoing challenge in regenerative biology is the
difficulty in controlling the heterogeneous nature of differ-
entiated progenies that are typically derived from more
primitive, pluripotent stem cells. In the case of ESCs, not
only do differentiated cultures most frequently contain
multiple lineages, but they can also contain residual
undifferentiated ESCs (Hentze et al., 2009). Although it is
generally believed that extended in vitro differentiation
results in decreased teratoma formation, previous studies
have found that ESCs differentiated for even extended
periods of time are still able to form teratomas (Hentze et
al., 2009). Furthermore, cultures differentiated using
specific growth factors into predominantly definitive endo-
derm, including pancreatic progenitors, nonetheless could
form teratomas when transplanted into the epididymal fat
pad (Kroon et al., 2008). A promising approach to overcome
the problems of both heterogeneity and tumorigenicity is to
transplant cells after purification by sorting (Knoepfler,
2009). Although genetic-based selection techniques have
been very effective at eliminating teratoma formation (Li et
al., 2009), genetic modification of stem cells introduces
additional complexities and risks. In contrast, using MACS
Figure 1 Protein and transcript expression profiles of differentiated ESC mass cultures prior to sorting at EB7+21. (a) Nuclear PDX1
and EpCAM are coexpressed in many areas of the unsorted culture; (b) in some regions, not all EpCAM+ cells express PDX1, yet the
majority of PDX1+ cells do express EpCAM. (c) EpCAM is not present on cells that express K14, a marker of basal cells of stratified
squamous epithelia which are common cell types in differentiated ESCs (top), or in a human keratinocyte stem cell culture (bottom);
(d–g) EpCAM is not coexpressed with neural or mesenchymal markers (vimentin, striated myosin, β-tubulin, nestin); scale bars, 50 μm.
(h) Temporal expression patterns of key mesendoderm and definitive endoderm genes indicate that cultures are beyond gastrulation
stage at the time of sorting, since T (brachyury) and goosecoid (Gsc) transcripts are nearly absent by EB7+21, whereas Foxa2 and Sox17
remain highly expressed. Pdx1 transcripts are also more abundant in post-EB cultures. * P≤0.05.
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Figure 2 Isolation of EpCAM+SSEA1–SSEA3– cells from mass differentiated ESC cultures by MACS sorting results in highly enriched
EpCAM+ population diminished in undifferentiated ESC and extraembryonic endoderm transcripts. (a) Flow diagram of three-step sorting
strategy. In the first sort, SSEA1 antibody removes undifferentiated ESCs expressing SSEA1; next, extraembryonic endoderm is depleted
using SSEA3 antibody. A third sort selects for remaining EpCAM+ cells. (b) FACS analysis of MACS-sorted cells indicates a nearly
homogeneous population (96%) of EpCAM+ cells from an initial population that is approximately 50% EpCAM+. (c) Transcript levels ofOct4,
indicative of undifferentiated ESCs, decline gradually during in vitro differentiation and are further significantly reduced by MACS
sorting. * P≤0.05. (d) SSEA4, indicative of extraembryonic endoderm, was found on a subset of cells in unsorted EB7+13 cultures, but not
on similar stage cells sorted to select the EpCAM+SSEA1–SSEA3– population and then cultured for 2 days. Scale bar, 50 μm.
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Figure 3 Tumorigenicity of EpCAM+ SSEA1–SSEA3– cells. (a) ESCs were differentiated to the EB7+21 stage and selected for
EpCAM+SSEA1–SSEA3– cells according to the strategy in Figure 2a, and then sorted cells were immediately injected into subcutaneous
(SC) sites in immunodeficient NOD/SCID mice and allowed to remain for 6–24 weeks. Photograph shows a representative mouse in
which the unsorted, differentiated population grew into a teratoma by 6 weeks, but the sorted cell population did not. (b) Bar graph
indicating the percentage of inocula forming tumors at 6 weeks (or up to 24 weeks for EpCAM+ sorted cells) after SC transplantation of
106 cells of undifferentiated ESCs, sorted EpCAM+ cells, sorted EpCAM– cells, or unsorted cells previously differentiated to the EB7+21
stage (unsorted EB7+21) into recipient mice. Sorted EpCAM
+ vs undifferentiated ESC, Pb0.0001; sorted EpCAM+ vs unsorted EB7+21,
Pb0.0001; sorted EpCAM+ vs sorted EpCAM–, P=0.0549; sorted EpCAM– vs undifferentiated ESC, Pb0.0008; sorted EpCAM– vs unsorted
EB7+21, P=0.0152; undifferentiated ESC vs unsorted EB7+21, P=0.44; overall, Pb0.0001. (c) Kaplan-Meier curve indicating the
proportion of animals free of tumors, defined as the presence of a nodule 3 mm or larger in diameter, at various times after
transplantation of 1×106 cells SC. Sorted EpCAM+ vs undifferentiated ESC, Pb0.0001; sorted EpCAM+ vs unsorted EB7+21, Pb0.0001;
sorted EpCAM+ vs sorted EpCAM–, P=0.0117; sorted EpCAM– vs undifferentiated ESC, Pb0.0001; sorted EpCAM– vs unsorted EB7+21,
P=0.0091; undifferentiated ESC vs unsorted EB7+21, P=0.0025; overall Pb0.0001. N differs between (b) and (c) in two categories
because some animals did not have their injection sites measured serially.
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purify a population of cells from genetically unaltered ESCs
that achieves two important aims: removal of all teratoma-
forming potential and selection of definitive endoderm-
committed cells, as further documented below.Transcript and protein analysis of unsorted versus
EpCAM+ sorted cells
To characterize the enrichment achieved by the MACS
sorting protocol, we began by examining the differentiation
stage attained in unsorted cultures at 1–3 weeks after EB
plating. Brachyury (T), Goosecoid (Gsc), Sox17, Foxa2, and
Pdx1 represent transcripts expressed during gastrulation or
early periods of endoderm development. QPCR analysis
revealed that T and Gsc levels peak during EB formationand subsequently decline in monolayer culture after EB
plating. Conversely, Foxa2 and Sox17 transcripts increase
after plating and are maintained at high levels thereafter,
and Pdx1 levels increase postplating (Fig. 1h). This temporal
sequence is reminiscent of a pattern of endoderm gene
expression observed during embryogenesis: T, initiated
during early mesendoderm commitment, is not expressed
in visceral endoderm and is downregulated as cell fate
becomes restricted to definitive endoderm; Gsc expression
begins at e6.5 in the node and early definitive endoderm,
while Sox17 transcripts are present in both extraembryonic
and definitive endoderm. Sox17 expression begins in the
earliest e7.5 foregut and gradually strengthens in mid- and
hindgut regions before disappearing from the gut after e9.0
(Kanai-Azuma et al., 2002). Foxa2, found in both primitive
and definitive endoderm, is generally maintained in defin-
itive endoderm-derived tissues throughout adult stages,
Figure 4 Analysis of sorted cells. (a) FACS determination of the percentage PDX1+ cells in presort and postsort populations in four
independent experiments. (b) FACS dot plots of data from experiment 1 (a) showing coexpression of PDX1 and EpCAM in pre- and
postsorted cells, demonstrating efficient recovery of PDX1+ cells in the EpCAM+ sorted population. (c) Levels of gene transcripts
characteristic of different embryonic germ layers and ESCs in sorted cells compared to unsorted cells, showing enrichment of
endoderm markers relative to markers of other germ layers. * P≤0.05. (d) Phase contrast image of cells 24 h after sorting (upper), or
confluent cultures 4 days after sorting (lower), grown in medium containing 10% SR and 50 ng/ml FGF10. (e) Cells at 4 days postsorting
virtually all costain for Sox17 and Foxa2, consistent with a culture composed solely of definitive endoderm cells. Scale bars, 100 μm
(d), 50 μm (e).
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be expressed at e8.5 and persists in pancreatic β and some
duodenal cells throughout life. The pattern observed
suggests that endoderm present in later ESC cultures is
most comparable to postgastrulation embryonic endoderm in
which gut regionalization has begun.
To evaluate the capacity of sorting for PDX1enrichment,
the frequency of PDX1+ cells was determined by flow
cytometric analysis in sorted and unsorted populations at
EB7+21. The percentage of PDX1+ cells can be highly variable
in spontaneously differentiated cultures before sorting,
although enrichment generally occurs to the same extent,
approximately 2- to 5-fold (Fig. 4a). PDX1 expression may
vary in presort populations because spontaneous differenti-
ation is dependent upon relatively rare, variable events. In a
complex multistep process, it should be anticipated that,
occasionally, differentiation to the desired lineage may be
poor. In addition, PDX1+ cells are very efficiently included in
the sorted EpCAM+ population, as FACS analysis of pre- and
postsorted PDX1+ cells indicates that virtually all PDX1+ cells
are also EpCAM positive (Fig. 4b).
To determine whether MACS sorting simultaneously elim-
inates cells of other germ layers while enriching for definitive
endoderm, we analyzed levels of transcripts characteristic of
mesodermal and neural lineages and compared them to
endoderm marker transcripts (Fig. 4c). Vimentin expression,
indicative of mesenchyme, was reduced 20-fold in sorted
cells, while Nkx2.5 transcripts, specific for cardiac muscle,
and neural/mesenchymal markers Sox1, ß-3tubulin, and
Nestin decreased 2- to 5-fold. Conversely, endoderm-specific
markers including Surfactant Protein C (SftpC), expressed in
lung progenitors, and Transthyretin (Ttr) and Tyrosine
aminotransferase (Tat), markers of hepatic development,
increased by 3- to 5-fold. We also observed a 500-fold increase
in the hindgut marker, Caudal box 1 (Cdx1). Genes charac-
teristically expressed in the distal foregut including Prox1,
specific for the liver/pancreas region (Burke and Oliver,
2002), as well as pancreatic markers Pdx1, YY, Ngn3, and
Insulin (Ins1), were also expressed at higher levels (4- to 10-
fold) in selected EpCAM+ cells compared with the presort
population. Taken together, these results support the notion
that positive sorting for EpCAM, together with removal of
SSEA1- and SSEA3-expressing cells, enriches for endoderm-
restricted cells.
Freshly sorted EpCAM+ cells were morphologically homog-
enous and could be expanded in MES medium minus LIFFigure 5 Differentiation of sorted EpCAM+ cells in vitro. (a) Dif
medium containing 10% serum replacement (SR) and FGF10, coated
medium (SFDM) containing ITS (SFDM/ITS) FGF10, nicotinamide, and
and doses). They were then grown for 7 additional days in SFDM as ab
and BTC were added. (b) Phase contrast image of cells beginning to a
cultures 3 days after Matrigel addition, showing formation of tubula
white stippling) developed after 8–10 days in SFDM. (inset) H&E-st
primarily composed of simple cuboidal epithelium. (e) Cells incorp
observed as a hollow ball in a single confocal slice (inset shows stac
SFDM. Three-dimensional structures express pancreatic progenitor pr
(i) Hnf6, (j) Prox1, and (k) Sox9. Scale bars, 100 μm (b,c,d), 50 μm
differentiation in SFDM for 8 days compared to freshly sorted cells dem
an increase in Pdx1, Pax4, and Nkx2.2 transcripts. Pax4was undetect
fold change.supplemented with 10% SR and FGF10, the latter routinely
included as it has been previously shown to promote
proliferation of embryonic pancreatic precursors (Bhushan
et al., 2001). Confluent monolayers formed after 2–5 days
(Fig. 4d), indicating both survival and prompt cell division in
culture following the sorting process. Nearly all sorted cells
costained for FOXA2 and SOX17 (Fig. 4e), key proteins
expected in early definitive endoderm.Differentiation potential of sorted EpCAM+ cells
In vitro differentiation capabilities of sorted cells were
examined by switching cells to a series of serum-free
differentiation media (SFDM; Fig. 5a). Dramatic changes in
morphology occurred rapidly in confluent monolayers fol-
lowing coating with Matrigel and renewal with SFDM/ITS
including nicotinamide, Exendin-4, and FGF10. By 24 h, cells
were clearly aggregating (Fig. 5b) and by 3–7 days became
organized into tubular/cystic structures (Fig. 5c) that
stained intensely for EpCAM (Fig. 5e). Abundant cysts evident
8–10 days after Matrigel addition (Fig. 5d) were comprised
predominately of simple epithelium (Fig. 5d, inset). PDX1
expression was particularly notable in all such structures
(Figs. 5f and g), which were also strongly EpCAM+ (Fig. 5g).
Compared to freshly sorted EpCAM+ cells, the gene and
protein expression profile of cystic structures suggested
further differentiation into prospective foregut or pancre-
atic bud-like epithelium. Protein markers of committed
pancreatic bud epithelium including HNF4α, HNF6, PROX1,
and SOX9 were highly expressed in 8-day cystic structures
(Figs. 5h–k), in addition to PDX1. Transcript levels of these
genes were quite abundant in cystic stages, as gauged by low
ΔCt values (ΔCt≤5), as well as in postsort d0 cultures
(Fig. 5l). Although transcript levels of genes did not change
significantly after sorting, except for increased Pdx1, Pax4,
and Nkx2.2 (Fig. 5l), the amount of protein detected
increased greatly. Very few cells in early monolayers were
positive by immunofluorescence staining for any of these
markers (Fig. S2), indicating that differentiation over this
interval may have involved changes in gene translation
rather than transcription; alternatively, changes in ubiqui-
tination or protein degradation could have occurred. In
contrast to high levels of pancreatic progenitor transcripts,
endocrine specification transcripts, such as Ngn3, Nkx6.1,
and MafA were low in abundance (ΔCt≥10) and did notferentiation scheme: sorted cells were grown to confluency in
with Matrigel, and then switched to serum-free differentiation
exendin-4 for 8–10 days (see Materials and methods for details
ove except that B27 was substituted for ITS (SFDM/B27) and HGF
ggregate 24 h after Matrigel addition. (c) Phase contrast image of
r/cystic structures. (d) Numerous cystic structures (outlined in
ained tissue section of structures at 10 days in SFDM medium,
orated into tubules are strongly EPCAM+. (f) Cystic structures,
ked image), are entirely PDX1+ and (g) EpCAM+ after 10 days in
oteins after 8 days of differentiation in SFDM including (h) Hnf4α,
(d inset, e–k). (l) Gene transcript levels of sorted cells after
onstrate stable expression of pancreatic endodermmarkers and
ed in postsort d0 cells; a Ct value of 40 was used in calculating the
151Non-tumorigenic endoderm stem cellsincrease substantially under SFDM/ITS conditions (Fig. 5l).
Interestingly, MafB transcripts were easily detected (ΔCt=6)
and Pax4 and Nkx2.2 transcripts increased significantly
following culture in SFDM/ITS.
After an additional 7 days in SFDM/B27 containing HGF
and BTC, gene expression analysis showed sustained enrich-
ment of pancreas progenitor transcripts (Pdx1, Prox1, Sox9),
whereas the expression of markers of other, nonpancreatic
endoderm regions including thyroid (Nkx2.1 and Thyroidstimulating hormone receptor [TshR]), liver (Tat), and
hindgut (Cdx1 and Hoxb13) remained very low or declined
(Fig. S3). Transcript and expression levels of EpCAM
remained high throughout the entire differentiation period
(not shown). Expression of the early lung marker Nkx2.1
decreased, while expression of the differentiated lung
marker SftpC increased (Fig. S3). Hence, further differenti-
ated cultures showed sustained maintenance of high levels of
pancreatic bud epithelium markers and reduced anterior
Figure 6 In vivo differentiation of EpCAM+ cells. Freshly sorted cells were injected SC into NOD/SCID mice and resulting growths
were examined by histological staining, immunohistochemistry, and QPCR. (a) H&E-stained tissue section of typical teratoma formed
after transplantation of either ESCs, unsorted differentiated EB7+21 cells, or sorted EpCAM
– cells. (b) H&E-stained tissue section of a 1-
mm nodule formed after transplantation of EpCAM+ cells, composed of numerous cystic/glandular structures. (c) Higher magnification
of area in panel b, showing simple cuboidal epithelium lined cysts. (d) Mucicarmine staining of a similar section, showing stained
intracellular vacuoles (arrow) indicating mucin containing goblet cells such as those found in intestine, bronchial, or pancreatico-
biliary ductal cells. (e,f) Immunohistochemical analysis of two different nodules derived from inoculation of EpCAM+ cells reveals that
virtually all EpCAM+ (green) epithelial cells lining the cysts costain for PDX1 (red). (g) Immunohistochemical staining of embryonic day
13.5 mouse pancreas sections illustrates the similarity of normal embryonic pancreatic tissue to the cystic/glandular structures
derived from EpCAM+ cells, with corresponding costaining of PDX1 (red) and EpCAM (green) in most cells. Scale bars, 500 μm (a),
200 μm (b), 50 μm (c–g). (h) Gene transcript levels of five individual primary nodules formed after SC injection of EpCAM+ cells. All
nodules contain high levels (low ΔCt) of PDX1 and YY transcripts, signature genes for posterior foregut cells, and are highly enriched
above postsort levels. (i) Fold change of transcript expression of all nodules relative to the mean. A value of 19.00 was used as the ΔCt
cutoff value. Nodule 2 did not yield enough material for analysis of all genes.
152 B. Kahan et al.foregut, liver, and hindgut marker expression, indicating a
potential shift in the profile of regional endoderm expression
toward pancreatic lineages. However, despite their progen-
itor phenotype, differentiated sorted cells did not increase
their endocrine-specific gene expression under the in vitrodifferentiation conditions tested. Although purified EpCAM+
cells expressed high levels of Pdx1, Prox1, Sox9, Hnf6, and
Hnf4α, they lacked significant expression of Ptf1a, a
transcription factor considered to be essential for in vivo
pancreas specification. Indeed, this set of markers could
153Non-tumorigenic endoderm stem cellsindicate a posterior foregut progenitor lineage that has
potential for both liver and pancreas. Protocols to differen-
tiate these cells into insulin+ cells have yet to be devised.
Achieving more complex levels of differentiation may
require more robust growth factor differentiation protocols
than those employed here. Additionally, development of
pancreatic epithelia in isolation in vitro may require signals
from surrounding cells, including mesenchyme. Recombining
the purified population with other cell types prior to
transplantation is another method to further investigate
the potential of these cells to achieve pancreatic cell fates.
Clearly, close monitoring would be essential to ensure that
additional culture manipulations or introduced cell interac-
tions did not result in altered tumorigenic status of the
sorted cells.
Although numerous different growth factor strategies
have been developed to derive β-cell-like cells from ESCs,
thus far they have yielded relatively small numbers of
pancreatic endocrine cells in vitro (Li et al., 2009; Shi et al.,
2005; D'Amour et al., 2006; Phillips et al., 2007; Johannesson
et al., 2009; Borowiak et al., 2009; Chen et al., 2009).
Interestingly, superior results to date have been obtained by
injecting heterogeneous populations of endoderm-commit-
ted, though not necessarily endocrine-producing cells, into
epididymal fat pads (Kroon et al., 2008), suggesting a better
strategy may be to obtain discrete populations of pancreatic
progenitors that can be further differentiated in vivo. Our
system may contribute to defining those signals that
complete the final differentiation steps to mature β-cells
from progenitor cells.Development of nontumorigenic foregut endoderm
cells in vivo
Tumors formed after injection of either undifferentiated ESC
or differentiated, unsorted cells were typical teratomas,
including neural, mesodermal, and gut structures (Fig. 6a).
No similar teratomas ever developed from EpCAM+ sorted
cells. However, in approximately 40% of animals injected
directly with fresh-sorted cells having no culture interval,
small benign nodules arose that never exceeded 3 mm, even
after 6 months or more of residence in vivo. All were similar,
consisting solely of glandular epithelia lined by simple
epithelial cells (Figs. 6b and c). Some cells lining the cysts
contained mucin, characteristic of intestinal epithelial cells
and/or ductal cells of the pancreatico-biliary system
(Fig. 6d). Remarkably, the majority of cells lining the cysts
expressed PDX1 in addition to EpCAM by immunohistochem-
istry (Figs. 6e and f), with no insulin or glucagon detected
(not shown), thereby closely resembling e13.5 pancreatic
ducts that show similar coexpression of PDX1 and EpCAM
(Fig. 6g). A gene expression analysis of five independent
nodules for a panel of endoderm and pancreatic genes
showed that all nodules expressed high transcript levels (low
ΔCt values) of YY, a marker specific for definitive foregut
endoderm in the early embryo (Hou et al., 2007), and Pdx1,
the first pancreas transcription factor, that were signifi-
cantly enriched over levels present in the fresh-sorted
inoculum cells (Fig. 6h). Moreover, the nodules showed
strong similarities in their overall expression pattern
(Fig. 6i), including low or undetectable levels of Oct4,Ngn3, Ptf1a, Cdx1, and Ins1 transcripts, and modest amounts
of Sox2 and Prox1.
Morphologically identical cystic nodules were derived
from three different ESC lines (R1 (Nagy et al., 1993), D3,
and YC5 (Hadjantonakis et al., 2002)) following injection of
fresh-sorted cells, suggesting that a generalized basis exists
for this phenomenon. We considered that a unique class of
PDX1+ precursor cells might exist among cells of the sorted
population having extensive capacity for cell division, but
only a limited potential for growth in vivo. We tested this
hypothesis by culturing cells in vitro from nodules generated
from fresh-sorted cells in an effort to establish a PDX1+ cell
line.Candidate foregut stem cell line established in vitro
from nodule-derived cells
A small nodule developed from MACS-sorted cells injected
6 months previously was minced and explanted into tissue
culture. The outgrowth cells exhibited stem cell-like
morphology (Fig. 7a), displaying a high nuclear-to-cytoplas-
mic ratio and forming compact colonies, but unlike ESCs,
were uniformly PDX1+/OCT4– (Fig. 7b). These cells have
been in continuous culture for over 7 months without signs of
senescence and were readily cloned (not shown); a selected
clonal population was uniformly HNF4α+ and K19/K7+
(Figs. 7c and d) as well as PDX1+, EpCAM+ , and DBA+ positive
(not shown), an expression pattern consistent with that
expected of a posterior foregut population. On the other
hand, definitive endoderm markers, FOXA2 and SOX17, were
not expressed in all cells and were not always coexpressed
(Fig. 7e) in either cloned or early uncloned cells. This
pattern, in contrast to uniform coexpression of these
markers in cells cultured from the time of sorting, suggests
a phenotypic shift (or selection) in vivo, resulting in a more
mature committed endoderm fate in nodule-derived tissue,
since SOX17 levels progressively decrease along the gut tube
during early development and the gene is not expressed in
the gut after E9 (Kanai-Azuma et al., 2002), whereas FOXA17
remains expressed. QPCR analysis showed a gene expression
profile compatible with that of an endoderm-restricted
population, depleted of hallmark ESC, neural and mesoder-
mal gene transcripts, and enriched for endoderm genes
(Fig. 7f), compared to ESC levels. Regional endoderm
specification is suggested by the high relative expression
levels of mid/foregut genes, in particular Pdx1 and Cdx2, in
contrast to low expression of more anterior endoderm genes,
including Nkx2.1, SftpC, and Pax8, as well as posterior
endoderm genes, such as Cdx1, and Hoxb13. We measured
the total amount of endoderm gene transcripts present in
cells by determining ΔCt values (low ΔCt values indicate high
expression) for a panel of pancreas- and foregut-restricted
gene transcripts, which revealed that genes most highly
expressed included Gata4, Pdx1, Cdx2, Foxa2, Hnf4a, Sox17,
Sox9, Hex, Hnf1β, and Hlxb9 (Fig. 7g). On the other hand,
very low or undetectable levels of Ngn3, Nkx6.1, Nkx2.2,
Ptf1a, MafA, Amylase, and Ins1 (dCT≥12) were found, thus
placing the cells in a differentiation hierarchy evocative
of early posterior foregut endoderm. Clearly, testing the
full range of differentiation capabilities of these cells is
of paramount importance.
154 B. Kahan et al.One hallmark of a stem cell line is the ability to be
propagated while maintaining a stable progenitor pheno-
type. To address this, we evaluated the expression levels of
23 genes, including Oct4, endoderm, pancreatic, and livergenes over a 7-week period of approximately 10 passages
(Fig. S4). Stable expression of definitive endoderm and
posterior foregut endodermmarkers indicates derivation of a
liver–pancreas restricted posterior foregut stem cell-like
155Non-tumorigenic endoderm stem cellspopulation (foregut stem cell or FGSC). Unlike previous
efforts to derive endoderm-committed proliferative cells
from ESCs (Seguin et al., 2008; Li et al., 2009), these FGSCs
appear to be nontumorigenic: when cells were injected
subcutaneously into immunodeficient animals, none (0/9)
formed large tumors, while again, small benign nodules
developed in some animals. Secondary nodules were
morphologically indistinguishable from primary nodules,
exhibiting multiple small cystic structures composed of
PDX1+/ EpCAM+ cells (Fig. 7h). Figure 7i demonstrates that
secondary nodules derived from candidate FGSC grown in
NOD/SCID (H-2Kd) mice expressed an MHC Class I antigen
characteristic of the originating ESC line (H-2Kb) but not the
host mouse.
Our working hypothesis is that nodules originate from rare
cells present in the sorted population that are relatively
undifferentiated but endoderm biased. We postulate that
this rare population is instrumental to the formation and
detection of in vivo growth of FGSCs revealed through
primary nodules, and furthermore, that FGSCs represent an
intermediate stage between pluripotent ESCs and fully
pancreas committed cells. It is possible that extended
(6 months) time in vivo enhanced further specification or
stabilization of PDX1 expression within some sorted cells
forming the nodule. Despite uncertainty over their origin,
FGSC cultures represent prime material to investigate steps
necessary to become pancreas, liver, and possibly stomach
or duodenal cells. Additional Materials and methods can be
found online atApplication of MACS selection strategy to HuESCs
We began to apply a similar MACS selection strategy to
human ESC-derived differentiated cell populations by mod-
ifying the selection strategy; SSEA antibodies were switched
to account for the differing SSEA antigen expression profile
of human ESCs and VYS cells compared to their mouse
counterparts (Fig. S5a). PDX1+ cells in human unsorted
differentiated cultures were also EpCAM+ (Fig. S5b), suggest-
ing that the scheme was likely to result in endoderm
progenitor enrichment. Similar to mouse ESC cultures, a
minority of presort cells expressed PDX1 or EpCAM. FACS
analysis of sorted human EpCAM+ SSEA1– SSEA4– cells showedFigure 7 Analysis of cells derived from an EpCAM+ primary nodule.
was removed 23 weeks after sorted EpCAM+ cells were inoculated i
fibroblasts. Cells resemble undifferentiated ESCs in morphology (inset
in the center of spread-out colonies and do not multilayer. (b) Immu
Oct4–, unlike ESCs. Cells also stained for other endoderm markers inc
Sox17 (e). (f) Transcript analysis of ESC, neural, mesoderm, and endod
of pluripotency genes (Oct4, Sox2, Nanog) is significantly decreased wh
Cdx2,) is enhanced. As expected, Sox17 and Foxa2 transcripts are ex
(Sox1), mesoderm (Nkx2.5, Meox1), primitive streak (T, Gsc), and hind
reduced expression in these cells compared to ESCs. Liver markers (Af
ESCs, consistent with being a posterior foregut-restricted cell populat
candidate FGSCs, of a panel of genes whose expression characterizes
highest transcribed genes are presented; other genes were less abun
secondary nodule derived from candidate foregut stem cells that had b
of the cystic/glandular structures which costained for PDX1 and EpCA
cysts express the H2kb haplotype of the injected cells. Host NOD/SCIDenrichment of human EpCAM+ cells comparable to that
obtained with mouse cultures (Fig. S5c). Selected EpCAM+
cells could grow in culture into homogeneously epithelial
sheets (Fig. S5d), and were enriched for definitive endo-
derm-restricted gene transcripts while being relatively
depleted of neural and mesodermal transcripts (Fig. S5e).Conclusion
We have outlined a simple procedure for eliminating the
tumorigenic potential from differentiated ESC populations of
both mouse and human origin. MACS-sorted SSEA1–/SSEA3–/
EpCAM+ cells never formed teratomas. Significantly, the
enriched cells have limited proliferative capacity in vivo and
are lineage-restricted; the gene expression pattern of sorted
cells indicates posterior foregut regional endoderm specifi-
cation. Freshly sorted cells can be amplified and differen-
tiated in vitro to express key pancreatic progenitor proteins
including PROX1 and SOX17. The sorted definitive endoderm
population includes or gives rise in vivo to PDX1+ putative
FGSC cells, which are capable of extensive proliferation and
express a repertoire of genes indicative of endoderm-
committed progenitor cells. Nongenetic methods to remove
teratoma-forming potential that also enable isolation of
desirable cell types may reduce therapeutic risks of using
ESC-derived populations.Materials and methods
Cell maintenance and differentiation
Mouse ESC lines used were D3, purchased from ATCC, and R1
and YC5 ESC lines, generously provided by A. Nagy.
Undifferentiated ESCs were maintained as previously de-
scribed (Kahan et al., 2003). Cells sorted by MACS were
subsequently cultured at 4×105 cells per 15 mm well in MES
medium without LIF plus 10% serum replacement (SR) and
FGF10 (50 ng/ml). 10% FCS was added for 24 h to facilitate
cell attachment and thereafter replaced with 5 μg/ml
fibronectin; medium was changed daily. Confluent mono-
layers formed after 2–4 days were differentiated by coating
with 10 μl/well Matrigel (Collaborative Research-BD, Cat.(a) Phase contrast image of cells that grew out of nodule. Nodule
nto immunodeficient mice, minced, and plated onto irradiated
), but the growth pattern differs in that they tend to form lacunae
nohistochemical analysis demonstrated that cells are PDX1+ and
luding Hnf4α (c), ductal cytokeratins K19 and K7 (d), and Foxa2/
erm-restricted genes shows that compared to ESCs, the expression
ereas the expression of foregut endoderm-restricted genes (Pdx1,
pressed at higher levels than in ESCs. The expressions of neural
gut genes (Hoxc4, Hoxb13, Cdx1) are either not detected or show
p, Tat) are also more abundantly expressed in these cells than in
ion. (g) QPCR analysis of EpCAM+ primary nodule-derived cells, or
various stages of pancreas development Transcript levels of the
dant or not detected. (h) Immunohistochemical analysis of small
een inoculated into immunodeficient mice shows reestablishment
M, similar to the parent or primary nodule. (i) Secondary EpCAM+
mice are H2Kd. Scale bars, 50 μm (a–e) and 100 μm (h,i).
156 B. Kahan et al.No. 354234) and feeding with a serum-free differentiation
medium (SFDM) composed of DMEM/F12 (8 mM glucose)
containing 0.1 mM nonessential amino acids (NEAA), 2 mM
glutamine, 0.11 mM β-mercaptoethanol, ITS (5 μg/ml insu-
lin, 5 μg/ml apo-transferrin, 5 ng/ml selenite), 0.2% BSA,
10 mM nicotinamide, 10 nM Exendin-4, and 50 ng/ml FGF10
(R&D Systems). At 8–10 days after Matrigel addition, cells
were grown for another 7 days with SFDM containing 1% B27
(Invitrogen) instead of ITS (SFDM/B27), plus 10 ng/ml HGF
(R&D Systems), and 1 μM Betacellulin (BTC) (R&D Systems).
Subcutaneous nodules from sorted EpCAM+ cells were
explanted by cleaning the nodule in PBS under a dissecting
microscope, finely mincing the cleaned tissue with opposing
scalpels, and placing it on an irradiated fibroblast feeder
layer in medium consisting of MES minus LIF containing 20%
SR, 1% B27, and 50 ng/ml FGF10. Within 1–2 weeks, areas
resembling stem cells spread from the explant. The cell line
described originated from differentiated D3 ESCs. Initially,
cells were transferred by manual selection using a pulled
Pasteur pipette. The addition of a ROCK inhibitor (Y-27632,
Sigma-Aldrich) significantly aided survival during the trans-
fer of early passages. Later passages were accomplished
using limited dispase digestion, as single cells did not survive
transfer. Additional Materials and methods can be found
online at doi:10.1016/j.scr.2010.10.003.
MACS separation
Cell separations were performed using MACS LD and LS
columns according to the protocol of the manufacturer
(Miltenyi Biotec), except that azide was not included and the
incubation/wash solution was ice-cold DMEM/HEPES with
10% FCS.
Transplantation studies
Teratoma formation was evaluated by injecting 1–2×106
cells subcutaneously into 6- to 8-week-old male NOD/SCID
mice (Jackson Laboratory, Bar Harbor, ME). The maximal
diameter of the masses was measured every 2–3 days for up
to 23 weeks. In some cases, small nodules or large tumors
were harvested and processed for immunofluorescence
staining, hematoxylin and eosin staining, or RNA isolation.
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